Vaccine Development

Vaccines are critical to the eradication of infectious diseases worldwide. To achieve the FHI Clinical vision of a world where advances in vaccines help all people live longer, healthier lives, we’ve spent years honing our processes to respond to the urgency and complexity of vaccine trials, developing our global network of research-ready investigators and sites, and partnering with leading public and private medical research organizations, pharmaceutical and biotechnology companies, academic institutions, governments and non-governmental organizations.

Related Resources


Africa’s Potential for Clinical Research


Global Vaccine Development


Full-Service Global Support for COVID-19 Studies

Indication Overview

Our Clinical Trial Experience With Malaria


Our Experience in sub-Saharan Africa


Follow the Epi: Finding TB-Prevalent Populations to Guide TB Vaccine Protocol Design


About the PREVAIL Network

Case Study

Phase II Trial of a Chikungunya Vaccine in the Caribbean